Zohm®-D - The Vitamin D Sublispray®
Vitamin D is a group of fat-soluble vitamin which is essential for the growth and development of the human body throughout the life cycle. In humans, the most essential compounds in this group are vitamin D3 (Cholecalciferol) and vitamin D2 (Ergocalciferol). Once vitamin D enters the circulation, it accumulates in the liver within a few hours. In the liver, vitamin D undergoes hydroxylation and soon thereafter, it appears in the circulation as 25-hydroxyvitamin D3 [(25(OH)D3]. The serum concentration of 25(OH)D3 is considered the best indicator of systemic vitamin D status.
In children, vitamin D deficiency gives birth to rickets, a disease characterized by the loss of bone tissue to properly mineralize, resulting in soft bones and skeletal deformities. In adults, the deficiency of vitamin D can lead to osteomalacia, resulting in weak bones. Symptoms like bone pain and muscle weakness indicate inadequate vitamin D levels in the body. Vitamin D deficiencies can be treated through nutritional supplements that can be administered via oral, sublingual, or intravenous routes.
Zohm-D® is a Vitamin-D product bu Vitonnix® using Sublispray® technology. Its efficacy is proven by trials as well as its numerous raving fan patients.
One study was conducted on a cohort of adult male and female subjects diagnosed with low serum levels of vitamin D. Participants consuming any nutritional supplement within 2 years before the start of the study were excluded. The participants were equally divided into three groups viz. test 1, test 2 and placebo. The test 1 group received one serving per day of Vitonnix® vitamin D Sublispray® (sublingual spray). The test 2 group received one vitamin D oral tablet per day. The placebo group received one starch tablet orally per day. The serum concentration of 25 (OH) D3 was measured at 0, 2, 4 and 6 weeks in all three groups.
At the end of 6 weeks study, the mean serum 25 (OH) D3 concentration in the test 1 group increased significantly many times from the initial whereas, in the test 2 group, the 25(OH)D3 concentration increased by a scant figure. For maintenance, a lower dose was found adequate.
A lot of our patients with longstanding, intractable deficiency also responded well. This included patients with non-healing wounds & fractures. Zohm-D® works by providing adequate supplementation, improving the body’s ability to heal.